SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
SANUWAVE Health, Inc.NASDAQ: SNWV
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin widens to -15.0%
Net margin was -15.0% in Q1 FY2026, up 45.8 pp from a year earlier. On a trailing-twelve-month basis it was 36.2%, up 126.1 pp year over year. Over 3 fiscal years it widened by 88.3 pp.
Context
- Net margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 1 analysts of -1.4% for the fiscal year ending Dec 2026, down from 26.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -15.0%-61.6 pp QoQ
- Last fiscal yearDec 2025
- 26.8%+122.9 pp YoY
- LTMMar 2026
- 36.2%+126.1 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 26.8%
- Year-over-year change
- +122.9pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.8% | +122.9pp |
| FY2024 | 2024-12-31 | -96.1% | +30.4pp |
| FY2023 | 2023-12-31 | -126.5% | -65.0pp |
| FY2022 | 2022-12-31 | -61.5% | +148.0pp |
| FY2021 | 2021-12-31 | -209.5% | — |
Net Margin vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 net margin of 36.2% is the highest of the 10 companies compared; the peer median is -71.9%.
- Its year-over-year change of +126.1 pp is the 2nd highest of 10, against a peer median of +16.4 pp.
- Over three fiscal years its change of +88.3 pp compares with a peer median of +71.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 36.2% | +126.1 pp | +88.3 pp | |
| LTM Mar 2026 | -7.1% | +1.0 pp | +15.7 pp | |
| LTM Mar 2026 | -46.8% | +16.4 pp | +71.2 pp | |
| LTM Mar 2026 | -62.1% | -30.8 pp | +6.4 pp | |
| LTM Mar 2026 | -63.7% | +35.1 pp | +72.9 pp | |
| LTM Mar 2026 | -71.9% | -36.2 pp | +17.1 pp | |
| LTM Mar 2026 | -214.2% | +98.3 pp | -1063.2 pp | |
| LTM Mar 2026 | -266.9% | +75.4 pp | +325.9 pp | |
| LTM Dec 2025 | -576.1% | -101.8 pp | +650.8 pp | |
| LTM Mar 2026 | -1427.1% | +1583.0 pp | +1108.5 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding SNWV) | -71.9% | +16.4 pp | +71.2 pp | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.01M | 16.74M | 20.4M | 32.63M | 44.05M |
| Cost of Revenue | 4.99M | 4.33M | 6.04M | 8.08M | 10.08M |
| Gross Profit | 8.02M | 12.41M | 14.36M | 24.55M | 33.97M |
| Gross Margin | 61.7% | 74.1% | 70.4% | 75.2% | 77.1% |
| Research & Development | 1.1M | 567K | 579K | 673K | 1.35M |
| Selling, General & Admin | 20.28M | 20.03M | 13.57M | 17.67M | 26.79M |
| Operating Expenses | 22.17M | 21.36M | 14.9M | 19.13M | 29.02M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| EBITDA | (18.9M) | 4.79M | (9.15M) | (16.56M) | 19.43M |
| EBITDA Margin | -145.3% | 28.6% | -44.9% | -50.8% | 44.1% |
| Operating Income | (14.14M) | (8.95M) | (540K) | 5.42M | 4.95M |
| Operating Margin | -108.7% | -53.5% | -2.6% | 16.6% | 11.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.1M | 14.13M | 15.62M | 13.64M | 6.25M |
| Other Income / Expenses | (13.09M) | (1.34M) | (25.26M) | (36.76M) | 6.95M |
| Income Before Tax | (27.23M) | (10.29M) | (25.8M) | (31.35M) | 11.9M |
| Pre-Tax Margin | -209.3% | -61.5% | -126.5% | -96.1% | 27.0% |
| Income Tax Expense | 28K | 2K | 4K | 27K | 86K |
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Net Margin | -209.5% | -61.5% | -126.5% | -96.1% | 26.8% |
| EPS (Basic) | (19.72) | (7.02) | (12.19) | (7.03) | 1.38 |
| EPS (Diluted) | (19.72) | (7.02) | (12.19) | (7.03) | 0.41 |
| Weighted Avg Shares | 1.38M | 1.47M | 2.12M | 4.46M | 8.56M |
| Weighted Avg Shares (Diluted) | 1.38M | 1.47M | 2.12M | 4.46M | 9.08M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.